Proposed to present a mandate for a directive aimed at safeguarding workers from radiation hazards, as requested by the Commission.
Eckert & Ziegler (WKN: 565970), a leading player in the radiopharmaceutical industry, has reported strong financial performance following its 1-for-3 stock split effective mid-August 2025.
The company posted €80.6 million revenue in Q2 2025, a 3.7% year-over-year increase, with the medical segment driving the growth. This segment saw a 15% increase, primarily due to increased demand for lutetium isotopes and expansion in contract manufacturing [2][3]. Net income rose 7.5% YoY to €11.7 million in Q2 2025, with earnings per share (EPS) sharply increasing to €0.56 from €0.17 in the same quarter last year [2][3]. Adjusted EBIT for the first half of 2025 was €35.4 million, up 9% [1].
Eckert & Ziegler confirmed its 2025 full-year revenue guidance of around €320 million, forecasting an 8% increase over 2024 and adjusted EBIT growth of nearly 20% to about €78 million. The company aims to overcome challenges like a cyberattack and supply disruptions earlier in the year [1].
Despite solid financials, the share price dropped about 7% shortly after earnings and split, trading recently near €60.50 on the Xetra scale. However, when adjusted for the split, Eckert & Ziegler's stock is performing extremely well today, with a 5.9% gain [1][4][5]. The value of the stock has been reduced to a third due to the stock split, making it more accessible to investors.
The stock split, effective August 15, 2025, tripled the number of outstanding shares to improve liquidity without changing total market capitalization [5]. Eckert & Ziegler remains among the stronger titles in the small-cap index so far this year.
The company's stock is included in the DER AKTIONÄR Biotech Supertrends Index, which bundles the performance of 12 innovative biotech companies [6]. DER AKTIONÄR maintains its positive assessment of Eckert & Ziegler's stock and the radiopharmaceutical market in particular [6].
Last Friday, Eckert & Ziegler reported a slight increase in revenue and a higher operating result for the first half of the year [7]. Despite being the weakest stock in the SDAX on Friday, the company is showing solid mid-year revenue and profit growth, maintaining a confident full-year guidance [1][2][5].
Investors can participate almost one-to-one in the development of the 12 companies with the index certificate WKN DA0ABZ [6]. More information about the index can be found here.
[1] Financial Times [2] Bloomberg [3] Reuters [4] MarketWatch [5] CNN Business [6] DER AKTIONÄR [7] Handelsblatt
Read also:
- U Power's strategic collaborator UNEX EV has inked a Letter of Intent with Didi Mobility to deploy UOTTA(TM) battery-swapping electric vehicles in Mexico.
- Global Gaming Company, LINEUP Games, Moves Into Extensive Global Web3 Multi-Platform Gaming Network
- Gold nanorod market to reach a value of USD 573.3 million by 2034, expanding at a compound annual growth rate (CAGR) of 11.7%
- Approaching Manufacturing: 2027 Karma Amaris GT Coupé
